What are the major opportunities in the Gastric Cancer market? What are the strategies for the Gastric Cancer market?

For detailed insights on the major opportunities and strategies in the Gastric Cancer market, Read More

How does the Gastric Cancer market relate to the overall economy and other similar markets?

For detailed insights on Gastric Cancer's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Gastric Cancer market growth? SWOT analysis of the Gastric Cancer market.

For detailed insights on the key dynamics influencing the Gastric Cancer market growth and SWOT analysis of the Gastric Cancer industry, Read More

Gastric Cancer Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gastric Cancer Market Report 2026

Name: Gastric Cancer Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types), By Diagnosis (Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis), By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments), By Distribution Channel (Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Gastric Cancer Market Overview

• Gastric Cancer market size has reached to $3.64 billion in 2025

• Expected to grow to $7.29 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%

• Growth Driver: Impact Of Rising Obesity Rates On Gastric Cancer Treatment Demand

• Market Trend: Advancements In Personalized Treatment For Gastric And GEJ Adenocarcinoma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastric Cancer Market?

Gastric cancer is a malignant tumor that originates in the lining of the stomach. It often begins in the mucosa, the innermost layer of the stomach, and can spread to deeper layers, nearby tissues, or distant organs if not treated early. The disease is commonly associated with risk factors such as chronic infection with helicobacter pylori, smoking, excessive alcohol consumption, poor diet, and genetic predisposition.

The main types of gastric cancers are adenocarcinoma, lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others. Adenocarcinoma is the most common type of gastric cancer, originating in the glandular cells of the stomach lining. It is diagnosed using endoscopy, biopsy, imaging tests, exploratory surgery, and others, and is treated by surgery, radiation therapy, chemotherapy, targeted therapy, palliative care, and others. It is distributed through various channels such as hospital pharmacies, specialty and retail pharmacies, and others.

Gastric Cancer Market Global Report 2026 Market Report bar graph

What Is The Gastric Cancer Market Size and Share 2026?

The gastric cancer market size has grown rapidly in recent years. It will grow from $3.64 billion in 2025 to $4.19 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to high prevalence of helicobacter pylori infection, smoking and dietary risk factors, expansion of chemotherapy usage, hospital-based oncology care growth, development of surgical oncology.

What Is The Gastric Cancer Market Growth Forecast?

The gastric cancer market size is expected to see rapid growth in the next few years. It will grow to $7.29 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to advancements in immuno-oncology, growth in precision diagnostics, rising cancer screening programs, increasing aging population, development of novel targeted drugs. Major trends in the forecast period include rising adoption of targeted and immunotherapies, increased focus on early diagnosis and screening, expansion of personalized cancer treatment approaches, growing use of combination therapy regimens, improved multidisciplinary cancer care models.

Book your 30 minutes free consultation with our research experts

Global Gastric Cancer Market Segmentation

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

What Is The Driver Of The Gastric Cancer Market?

The rising obesity rates are expected to propel the growth of the gastric cancer market going forward. Obesity is a medical condition characterized by excessive body fat accumulation, often defined by a body mass index (BMI) of 30 or higher, which can lead to various health problems. Obesity rates are rising due to factors such as poor diet, lack of physical activity, sedentary lifestyles, environmental influences, and genetic predispositions. Excess body fat, particularly visceral fat around the abdomen, is associated with a higher risk of developing gastric cancer, as obesity triggers chronic inflammation and metabolic disturbances, both linked to cancer development, contributing to a rise in the demand for gastric cancer treatment. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that one in eight people worldwide now live with obesity, exceeding 1 billion individuals. Therefore, the rising obesity rates are driving the gastric cancer industry.

Key Players In The Global Gastric Cancer Market

Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd

Global Gastric Cancer Market Trends and Insights

Major companies operating in the gastric cancer market are focusing on developing technologically advanced solutions, such as companion diagnostic assays, to help ensure personalized treatment. A companion diagnostic assay is a test used to identify patients who are most likely to benefit from a specific therapeutic treatment based on the presence of certain biomarkers. For instance, in October 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, announced U.S. Food and Drug Administration (FDA) approval for the VENTANA CLDN18 (43-14A) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic for assessing CLDN18 protein expression in gastric and gastroesophageal junction (GEJ) adenocarcinoma. This assay identifies patients eligible for targeted treatment with VYLOY (zolbetuximab) by measuring CLDN18 protein variants, primarily CLDN18. 2. Utilizing the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, the test advances personalized healthcare, expanding treatment options for gastric and GEJ adenocarcinoma.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastric Cancer Market?

In January 2023, Leap Therapeutics, Inc., a U.S.-based biotechnology company focused on targeted oncology therapies, acquired Flame Biosciences, Inc. for an undisclosed amount. With this acquisition, Leap sought to bolster its oncology pipeline by integrating Flame’s clinical-stage anti-Claudin 18.2 antibody program, FL-301, thereby gaining exposure to a validated gastric (and pancreatic) cancer antigen. Flame Biosciences, a US-based company, is developing precision cancer therapeutics, including its Claudin 18.2-targeted antibody, which is particularly relevant for gastric/gastroesophageal cancer indications.

Regional Outlook

North America was the largest region in the gastric cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastric Cancer Market?

The gastric cancer market consists of revenues earned by entities by providing services such as cancer screening and early detection, genetic testing, personalized treatment planning, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric cancer market also includes sales of chemotherapeutic drugs, radiation therapy equipment, nutritional support products, surgical tools, and instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastric Cancer Market Report 2026?

The gastric cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastric cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gastric Cancer Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.19 billion
Revenue Forecast In 2035	$7.29 billion
Growth Rate	CAGR of 15.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Diagnosis, Treatment, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastric Cancer Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastric Cancer Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastric Cancer Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastric Cancer Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted And Immunotherapies

4.2.2 Increased Focus On Early Diagnosis And Screening

4.2.3 Expansion Of Personalized Cancer Treatment Approaches

4.2.4 Growing Use Of Combination Therapy Regimens

4.2.5 Improved Multidisciplinary Cancer Care Models

5. Gastric Cancer Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Treatment Centers

5.3 Specialty Oncology Clinics

5.4 Diagnostic Centers

5.5 Research Institutes

6. Gastric Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastric Cancer Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastric Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastric Cancer Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastric Cancer Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastric Cancer Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastric Cancer Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastric Cancer Market Segmentation

9.1. Global Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

9.2. Global Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

9.3. Global Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

9.4. Global Gastric Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

9.5. Global Gastric Cancer Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

9.6. Global Gastric Cancer Market, Sub-Segmentation Of Lymphoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Primary Gastric Lymphoma, Secondary Gastric Lymphoma

9.7. Global Gastric Cancer Market, Sub-Segmentation Of Gastrointestinal Stromal Tumor (GIST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Primary GIST, Metastatic GIST

9.8. Global Gastric Cancer Market, Sub-Segmentation Of Carcinoid Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

9.9. Global Gastric Cancer Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

10. Gastric Cancer Market Regional And Country Analysis

10.1. Global Gastric Cancer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastric Cancer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastric Cancer Market

11.1. Asia-Pacific Gastric Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastric Cancer Market

12.1. China Gastric Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastric Cancer Market

13.1. India Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastric Cancer Market

14.1. Japan Gastric Cancer Market Overview

14.2. Japan Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastric Cancer Market

15.1. Australia Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastric Cancer Market

16.1. Indonesia Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastric Cancer Market

17.1. South Korea Gastric Cancer Market Overview

17.2. South Korea Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastric Cancer Market

18.1. Taiwan Gastric Cancer Market Overview

18.2. Taiwan Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastric Cancer Market

19.1. South East Asia Gastric Cancer Market Overview

19.2. South East Asia Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastric Cancer Market

20.1. Western Europe Gastric Cancer Market Overview

20.2. Western Europe Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastric Cancer Market

21.1. UK Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastric Cancer Market

22.1. Germany Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastric Cancer Market

23.1. France Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastric Cancer Market

24.1. Italy Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastric Cancer Market

25.1. Spain Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastric Cancer Market

26.1. Eastern Europe Gastric Cancer Market Overview

26.2. Eastern Europe Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastric Cancer Market

27.1. Russia Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastric Cancer Market

28.1. North America Gastric Cancer Market Overview

28.2. North America Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastric Cancer Market

29.1. USA Gastric Cancer Market Overview

29.2. USA Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastric Cancer Market

30.1. Canada Gastric Cancer Market Overview

30.2. Canada Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastric Cancer Market

31.1. South America Gastric Cancer Market Overview

31.2. South America Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastric Cancer Market

32.1. Brazil Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastric Cancer Market

33.1. Middle East Gastric Cancer Market Overview

33.2. Middle East Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastric Cancer Market

34.1. Africa Gastric Cancer Market Overview

34.2. Africa Gastric Cancer Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastric Cancer Market Regulatory and Investment Landscape

36. Gastric Cancer Market Competitive Landscape And Company Profiles

36.1. Gastric Cancer Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastric Cancer Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastric Cancer Market Company Profiles

36.3.1. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Gastric Cancer Market Other Major And Innovative Companies

Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd

38. Global Gastric Cancer Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastric Cancer Market

40. Gastric Cancer Market High Potential Countries, Segments and Strategies

40.1 Gastric Cancer Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastric Cancer Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastric Cancer Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Gastric Cancer Market, Overview Of Key Products - Product Examples

Table 2: Global Gastric Cancer Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Gastric Cancer Market, Supply Chain Analysis

Table 4: Global Gastric Cancer Market, Major Raw Material Providers

Table 5: Global Gastric Cancer Market, Major Resource Providers

Table 6: Global Gastric Cancer Market, Major Manufacturers (Suppliers)

Table 7: Global Gastric Cancer Market, Major Distributors And Channel Partners

Table 8: Global Gastric Cancer Market, Key Technologies & Future Trends

Table 9: Global Gastric Cancer Market, Major Trends

Table 10: Global Gastric Cancer Market, Major End Users

Table 11: Global Gastric Cancer Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Gastric Cancer Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Gastric Cancer Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Gastric Cancer Market - TAM, US$ Billion, 2025

Table 15: Global Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Gastric Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Gastric Cancer Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Gastric Cancer Market, Sub-Segmentation Of Lymphoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Gastric Cancer Market, Sub-Segmentation Of Gastrointestinal Stromal Tumor (GIST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Gastric Cancer Market, Sub-Segmentation Of Carcinoid Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Gastric Cancer Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Gastric Cancer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Gastric Cancer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Gastric Cancer Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Gastric Cancer Market - Company Scoring Matrix

Table 100: F. Hoffmann La Roche Ltd. Financial Performance

Table 101: Merck And Co. Inc. Financial Performance

Table 102: AbbVie Inc. Financial Performance

Table 103: Sanofi S.A. Financial Performance

Table 104: Bristol Myers Squibb Company Financial Performance

Table 105: Global Gastric Cancer Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Gastric Cancer Market, Competitive Dashboard

Table 107: Global Gastric Cancer Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Gastric Cancer Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 109: Global, Gastric Cancer Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 110: Global, Gastric Cancer Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

List Of Figures

Figure 1: Global Gastric Cancer Market, Overview Of Key Products - Product Examples

Figure 2: Global Gastric Cancer Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Gastric Cancer Market, Supply Chain Analysis

Figure 4: Global Gastric Cancer Market, Major Raw Material Providers

Figure 5: Global Gastric Cancer Market, Major Resource Providers

Figure 6: Global Gastric Cancer Market, Major Manufacturers (Suppliers)

Figure 7: Global Gastric Cancer Market, Major Distributors And Channel Partners

Figure 8: Global Gastric Cancer Market, Key Technologies & Future Trends

Figure 9: Global Gastric Cancer Market, Major Trends

Figure 10: Global Gastric Cancer Market, Major End Users

Figure 11: Global Gastric Cancer Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Gastric Cancer Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Gastric Cancer Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Gastric Cancer Market - TAM, US$ Billion, 2025

Figure 15: Global Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Gastric Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Gastric Cancer Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Gastric Cancer Market, Sub-Segmentation Of Lymphoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Gastric Cancer Market, Sub-Segmentation Of Gastrointestinal Stromal Tumor (GIST), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Gastric Cancer Market, Sub-Segmentation Of Carcinoid Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Gastric Cancer Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Gastric Cancer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Gastric Cancer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Gastric Cancer Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Gastric Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Gastric Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Gastric Cancer Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Gastric Cancer Market - Company Scoring Matrix

Figure 100: F. Hoffmann La Roche Ltd. Financial Performance

Figure 101: Merck And Co. Inc. Financial Performance

Figure 102: AbbVie Inc. Financial Performance

Figure 103: Sanofi S.A. Financial Performance

Figure 104: Bristol Myers Squibb Company Financial Performance

Figure 105: Global Gastric Cancer Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Gastric Cancer Market, Competitive Dashboard

Figure 107: Global Gastric Cancer Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Gastric Cancer Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 109: Global, Gastric Cancer Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 110: Global, Gastric Cancer Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) – Market...

Gastric Ulcers Market Report 2026 - Global Outlook – By Drug Class (Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes ), By Diagnosis (Stool Test, Endoscopy, I...

Esophageal Cancer Market Report 2026 - Global Outlook – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By ...

Gastroparesis Market Report 2026 - Global Outlook – By Treatment Modality (Medications, Dietary Modifications, Medical Devices, Other Therapies), By Gastroparesis Type (Idiopathic, Diabetic, Post- Surgical, Other Types),...

Gastrointestinal Stromal Tumor Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Indication (Stomach, Small Intestine, Others Indications), By End-User (H...

Intestine Cancer Therapeutics Market Report 2026 - Global Outlook – By Treatment Type (Immunotherapy, Chemotherapy, Other Treatments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By App...

Invasive Ductal Carcinoma Therapeutics Market Report 2026 - Global Outlook – By Therapeutics (Targeted Therapy, Hormone Therapy), By Type (Hormone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2+), Triple-Negati...

Frequently Asked Questions

How big is the Gastric Cancer Market?

The Gastric Cancer market was valued at $3.64 billion in 2025, increased to $4.19 billion in 2026, and is projected to reach $7.29 billion by 2030.

What is the Gastric Cancer market growth?

The global Gastric Cancer market is expected to grow at a CAGR of 14.8% from 2026 to 2035 to reach $7.29 billion by 2035.

Who are the key players in Gastric Cancer market?

Some Key Players in the Gastric Cancer market Include, F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd .

What is the anticipated growth trend for the Gastric Cancer market?

Major trend in this market includes: Advancements In Personalized Treatment For Gastric And GEJ Adenocarcinoma. For further insights on this market. request a sample here

Which region has the most growth potential in the Gastric Cancer market?

North America was the largest region in the gastric cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.